Table of Contents >> Show >> Hide
- What ASX Is Actually Reviewing
- Why This Consultation Happened
- How the Current Rule Works
- What ASX Seems Most Open to Changing
- What the Data Says
- Why Investors Favor Tighter Rules
- Why Companies May Push Back
- Why U.S. Comparisons Matter
- Where the Consultation Stands Now
- What This Could Mean for Future Deals
- Experience and Lessons From the Dilutive-Bid Debate
- Conclusion
- SEO Tags
When stock exchanges start asking awkward questions, it usually means the market has already done the yelling for them. That is exactly what happened here. The Australian Securities Exchange Ltd, better known as ASX, opened a high-stakes conversation about whether listed companies should be allowed to issue big chunks of new stock for takeovers and mergers without first asking their own shareholders for permission. In plain English: if a company wants to bulk up through a deal and pays with a mountain of fresh shares, how much dilution is too much before investors deserve a vote?
This debate did not come out of thin air. It arrived with the force of a coffee spilled across a boardroom presentation deck, after investor backlash to a major cross-border acquisition put pressure on ASX to revisit long-standing listing rule exceptions. The result is a consultation that goes far beyond one transaction. It touches the balance between deal certainty and shareholder democracy, between board flexibility and investor protection, and between keeping public markets attractive and keeping them fair.
For lawyers, bankers, fund managers, and retail investors who would rather not decode listing rules for entertainment, this review matters because it could change how future M&A deals are structured on the Australian market. It could also reshape expectations around dilution, corporate accountability, and the role of shareholder votes in large strategic moves.
What ASX Is Actually Reviewing
The headline issue is whether ASX should tighten the rule that currently lets listed bidders issue a substantial amount of stock for a regulated takeover or merger without shareholder approval. Right now, under exceptions 6 and 7 to Listing Rule 7.2, a bidder can generally issue shares as consideration, or to help fund the cash portion of a regulated takeover or scheme, without a vote from its own shareholders, as long as the deal is not a reverse takeover.
That is a mouthful, so here is the practical version: if Company A wants to buy Company B and pays with stock, Company A may be able to avoid a shareholder vote even when the new shares significantly dilute existing owners. ASX is now asking whether that freedom has become too generous.
The consultation covers four areas, but the most talked-about piece is the proposed rethink of these bidder share issuance exceptions. The exchange also asked for feedback on whether shareholder approval should be required when a dual-listed company moves to ASX Foreign Exempt Listing status, when certain dual-listed companies delist from ASX, and whether broader approval rights should apply to major changes in a listed company’s activities.
Why This Consultation Happened
The spark was the James Hardie-AZEK transaction, which became the sort of deal that makes governance specialists sit up straighter in their chairs. Investors argued that the proposed issuance would materially dilute existing shareholders and alter their rights without a direct vote. That concern was compounded by worries around listing status and governance oversight if the company’s center of gravity shifted toward the United States.
Once that criticism landed, the broader question became impossible to ignore: should a listed company be able to transform its capital structure through a major acquisition without first checking whether its own owners are comfortable footing the bill?
ASX’s answer so far is not a final rule change. It is a public consultation. But the tone matters. The exchange made clear that market expectations have changed, and rules that have existed for decades may no longer match what investors think fair treatment looks like in 2026.
How the Current Rule Works
The Basic 15% Rule
ASX Listing Rule 7.1 generally limits a listed company from issuing equity securities over 15% of its issued capital in a 12-month period without shareholder approval. Eligible smaller entities may also seek an additional 10% annual placement capacity under Listing Rule 7.1A, but that requires a shareholder mandate and comes with conditions.
The Big Takeover Exceptions
Then come the exceptions that changed the mood in the room. Exceptions 6 and 7 in Listing Rule 7.2 exclude certain securities issued for regulated takeovers and mergers from that 15% cap. In effect, they can let a bidder issue stock well beyond the ordinary annual placement limit without going back to shareholders. The current ceiling for using those exceptions is less than 100% of ordinary shares on issue, and they do not apply to reverse takeovers.
That reverse takeover limit was introduced in 2017 because, in those deals, target shareholders can end up effectively taking control of the bidder. At that point, bidder shareholders look a lot like target shareholders in reverse, so a vote makes sense. The current consultation asks whether that logic should extend further, especially for deals that are not technically reverse takeovers but are still highly dilutive.
What ASX Seems Most Open to Changing
ASX’s initial view is not to abolish the exceptions altogether. Instead, it signaled that it would have no objection to reducing the limit to 25% of ordinary shares on issue for larger listed companies, particularly those in the S&P/ASX 300 or with market capitalization above A$300 million. Smaller issuers may continue to get more room, reflecting concerns that tougher rules could weigh more heavily on growth companies that rely on stock as a deal currency.
That approach tries to split the baby without cutting the market in half. Large issuers are more likely to have deeper financing options, stronger institutional investor bases, and a greater ability to run formal approval processes. Smaller companies often rely on flexibility, speed, and creative transaction structures to compete.
ASX also asked whether the threshold should instead be 75%, 50%, 25%, or some other number. That framing is important. It shows the exchange is not merely floating a symbolic tweak. It is testing the market’s appetite for real constraint.
What the Data Says
One of the most interesting parts of the consultation is that ASX did not just hand-wave about principle. It ran the numbers. Looking at the five years from July 1, 2020 to June 30, 2025, ASX identified 98 regulated takeover and merger transactions where an ASX-listed bidder issued securities for the acquisition under exceptions 6 and 7, excluding reverse takeovers.
That sounds like a lot until you read the next line. Those 98 transactions represented only about 5% of all acquisitions in which an ASX-listed bidder issued securities. In other words, these exceptions sit at the center of the governance debate while affecting a relatively small slice of the market. That helps explain why the exchange sees reform as manageable rather than apocalyptic.
ASX also modeled how many transactions might be affected under different thresholds. A 25% cap applied to all entities would have impacted around 46 transactions in the sample. A 25% cap applied only to larger issuers would have affected around 19. That is enough to matter, but not enough to send every M&A lawyer into witness protection.
Why Investors Favor Tighter Rules
Investors are not complaining just because dilution makes spreadsheets ugly. They are focused on economic ownership, voting power, and accountability. When a company issues a large slug of stock to fund an acquisition, existing shareholders can end up owning a much smaller piece of a very different business. Their upside gets spread thinner. Their influence shrinks. Their company may also inherit new strategy, leverage, integration risk, and governance complexity.
From that perspective, the argument for a vote is simple: if the deal meaningfully reshapes the ownership structure, shareholder rights, or strategic profile of the company, shareholders should have a formal say. This becomes even more compelling when the transaction is cross-border, accompanied by listing changes, or pitched as transformative. “Transformative” is often corporate shorthand for “please do not look too hard at the moving parts.”
Why Companies May Push Back
Boards and advisers see the other side. Requiring shareholder approval can slow deals down, inject execution risk, and weaken bidders in competitive or hostile situations. A listed bidder competing against a private buyer or cash-rich acquirer may lose the advantage if it must pause for a vote while the rival keeps sprinting.
There is also the issue of certainty. Sellers prefer buyers that can deliver. Financing markets prefer timetables. Lawyers prefer fewer variables. A mandatory bidder vote adds another hurdle, another possible failure point, and another opening for activists who may care more about leverage over management than the merits of the deal itself.
That does not make the pro-flexibility case wrong. It just means the exchange is trying to balance two legitimate goals that naturally annoy each other.
Why U.S. Comparisons Matter
ASX’s benchmarking matters because it shows this is not just a domestic governance food fight. The exchange compared its settings with peer markets and noted that U.S. venues such as Nasdaq and NYSE generally work with 20% style shareholder approval thresholds in certain issuance contexts, applied per transaction rather than through the same annual-cap model ASX uses.
That does not make the systems identical. They are not. U.S. rules involve their own exceptions, pricing tests, and exchange discretion. Still, the comparison undercuts the idea that a lower threshold would be some wild anti-business experiment. If anything, it suggests that ASX may have been relatively permissive in this area, particularly for large, stock-funded acquisitions.
The practical takeaway is that global issuers, advisers, and investors increasingly compare governance regimes across borders. If Australian rules look too loose, investor confidence suffers. If they look too rigid, listings may suffer. ASX is trying to avoid both outcomes at once, which is a little like trying to keep both ice cream and soup at exactly the same temperature.
Where the Consultation Stands Now
The public consultation formally sought submissions by December 15, 2025. ASX said it expected to release a consultation response in the first half of 2026 and indicated that any formal amendments would likely not be implemented until the second half of 2026.
By February 2026, ASX said it had received 45 submissions and would provide an update later in the half. That means the story is no longer about whether the market will engage. It already has. The next question is how far ASX is willing to go once the feedback is sorted, weighed, and translated into draft rule text.
What This Could Mean for Future Deals
If the rules are tightened, large ASX-listed bidders may need to think earlier about transaction structuring, financing mix, and shareholder messaging. Expect more careful sizing of stock consideration, more emphasis on debt and hybrid financing, and more board attention to investor relations before announcing big deals. Expect sellers to ask harder questions about timing and approval risk. And expect advisers to bill calmly through all of it.
If the final result lands near the 25% range for larger issuers, the biggest effect may not be fewer deals. It may be better-prepared deals. Boards would know earlier when they are likely to need shareholder support. Investors would know their vote matters before the cap table changes beyond recognition. That alone could improve trust, even if it makes some transactions slower and messier on the front end.
Experience and Lessons From the Dilutive-Bid Debate
In practical terms, the experience of a dilutive bid rarely feels academic to the people living through it. For company boards, the first emotion is usually urgency. A strategic acquisition comes along, management sees scale, synergies, or market access, and the internal mood quickly shifts from “interesting opportunity” to “we cannot miss this.” At that point, issuing stock can look elegant on paper. It preserves cash, keeps leverage under control, and signals confidence in future growth. Inside the boardroom, the deal often feels logical, even disciplined.
For long-term shareholders, though, the experience can feel completely different. They wake up to an announcement, skim the headline, and then discover that their slice of the company may be materially smaller by lunchtime. Even if management promises a stronger combined business, investors may still feel as though the transaction was done to them rather than with them. That emotional gap matters. Markets are not governed by feelings alone, but trust is a real form of capital. Once it leaks, boards usually discover that rebuilding it is slower than issuing shares.
Advisers who work around these deals often describe the same recurring pattern. First comes the financial logic. Then comes the governance question. Then comes the realization that the governance question may be the one that decides whether the financial logic ever gets to wear a tuxedo and go to the closing dinner. A transaction can be strategically sound and still become politically fragile if investors think the process denied them a meaningful say. That is one reason this ASX review matters so much. It is not only about dilution percentages. It is about the credibility of the path taken.
There is also a broader market experience worth noting. When rules are too loose, investors suspect that exchanges are favoring dealmakers over owners. When rules are too tight, companies complain that public markets have become obstacle courses while private capital gets a faster lane. The best regulatory frameworks tend to emerge when both sides are slightly unhappy but neither feels ambushed. That may end up being the real target of the ASX review: not perfection, but a rule set that is hard to game and easier to defend.
Retail investors, in particular, tend to experience these situations with the least influence and the most confusion. Institutions can call management, meet directors, or coordinate with proxy advisers. Smaller investors often get a dense announcement, a few headlines, and the vague sense that their ownership just went through a blender. Stronger approval requirements do not solve every information gap, but they do force companies to explain themselves more clearly. And clarity is rarely a bad thing in public markets, unless you are the person hoping nobody reads footnote 47.
The deeper lesson is that modern M&A is not only a financing exercise. It is a legitimacy exercise. If a board wants shareholders to accept short-term dilution for long-term gain, it increasingly needs more than a slick slide deck and a synergy number with plenty of zeros. It needs a process that looks fair, a rationale that feels credible, and rules that do not make investors wonder whether the game was nearly over before they were invited to the table.
That is why the ASX consultation deserves attention beyond Australia. It captures a global issue facing public markets: how to let companies stay nimble without turning shareholder rights into decorative office plants. No one wants a market where every acquisition requires a civic ceremony. But no one should want a market where transformative dilution slips through as routine paperwork either. Somewhere between those extremes is the sweet spot ASX is now trying to find.
Conclusion
Australian Securities Exchange Ltd’s consultation on dilutive bids and share-funded acquisitions is more than a technical cleanup of listing rules. It is a signal that market expectations have shifted. Investors want a stronger say when deals materially dilute their ownership or alter their rights. Companies still want the flexibility to move fast and compete. ASX is attempting to redraw that boundary with a more modern, more defensible set of rules.
The likely direction is not a ban on ambitious M&A. It is a more disciplined framework for when shareholder consent becomes part of the price of doing transformational business. If ASX lands near a lower threshold for larger issuers, the message will be clear: scale can still be bought, but not always without asking the owners first.